Aft, Forsyth & Company, Inc. Dexcom Inc Transaction History

Aft, Forsyth & Company, Inc.

$199 Million
Q3 2024

A detailed history of Aft, Forsyth & Company, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Aft, Forsyth & Company, Inc. holds 3,415 shares of DXCM stock, worth $259,130. This represents 0.11% of its overall portfolio holdings.

Number of Shares

3,415

Previous 3,415 -0.0%

Holding current value

$259,130

Previous $387,000 41.09%

% of portfolio

0.11%

Previous 0.2%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$110.31 - $140.45 $30,335 - $38,623	275 Added 8.76%	3,415 $387,000
Q1 2024 Apr 30, 2024	SELL	$114.22 - $140.1 $78,811 - $96,669	-690 Reduced 18.02%	3,140 $435,000
Q4 2023 Feb 09, 2024	SELL	$75.49 - $124.16 $75,112 - $123,539	-995 Reduced 20.62%	3,830 $475,000
Q3 2023 Nov 07, 2023	SELL	$86.06 - $137.93 $19,363 - $31,034	-225 Reduced 4.46%	4,825 $450,000
Q2 2023 Aug 14, 2023	SELL	$112.47 - $130.98 $448,192 - $521,955	-3,985 Reduced 44.11%	5,050 $648,000
Q1 2023 May 02, 2023	SELL	$104.0 - $122.92 $7,800 - $9,219	-75 Reduced 0.82%	9,035 $1.05 Million
Q4 2022 Feb 13, 2023	BUY	$84.98 - $122.67 $245,592 - $354,516	2,890 Added 46.46%	9,110 $1.03 Million
Q2 2022 Jul 28, 2022	BUY	$67.99 - $132.89 $292,696 - $572,091	4,305 Added 224.8%	6,220 $464,000
Q1 2022 May 10, 2022	SELL	$94.08 - $130.2 $106,310 - $147,126	-1,130 Reduced 37.11%	1,915 $980,000
Q3 2021 Nov 08, 2021	SELL	$106.71 - $143.18 $3,201 - $4,295	-30 Reduced 0.98%	3,045 $1.67 Million
Q2 2021 Jul 15, 2021	SELL	$80.99 - $107.93 $6,074 - $8,094	-75 Reduced 2.38%	3,075 $1.31 Million
Q4 2020 Feb 09, 2021	BUY	$78.0 - $104.5 $23,400 - $31,350	300 Added 10.53%	3,150 $1.17 Million
Q2 2020 Aug 06, 2020	SELL	$62.68 - $105.34 $1,567 - $2,633	-25 Reduced 0.87%	2,850 $1.16 Million
Q1 2020 May 11, 2020	BUY	$47.79 - $75.63 $137,396 - $217,436	2,875 New	2,875 $193,000

Others Institutions Holding DXCM

# of Institutions

1,013

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aft, Forsyth & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Aft, Forsyth & Company, Inc. with notifications on news.

Account

Aft, Forsyth & Company, Inc. Dexcom Inc Transaction History